Prelude Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.27M Sell
2024
Q4
$2.16M Buy
2024
Q2
Hold
2024
Q1
Hold
2020
Q3
Hold
2020
Q2
Hold
2019
Q3
Sell
2019
Q2
$194K Sell
2019
Q1
$556K Buy
2018
Q4
$237K Buy
2018
Q3
$29K Sell
2018
Q2
$755K Buy